Intra-articular pain pumps could lead to permanent joint damage
Pain meds injected into joint space may cause permanent damage.
InforMedix partners with Eaton Apothecary on Med-eMonitor
Eaton Apothecary to distribute InforMedix Holdings' Med-eMonitor.
Groups tell Congress to back off fight over ESA dosing decisions
Groups say cancer drug dosing best measured by CMS, Medicaid.
Mirixa introduces pharmacy marketing newsletter
Mirixa offers customizable newsletter, RxFYI, free newsletter for pharmacies
FDA committee recommends use of phosphate binders predialysis
Predialysis patients can benefit from phosphate binders, an FDA advisory committee has decided.
R.Ph. aims to make pharmacies a destination for immunizations
Seattle pharmacist Beverly Schaefer has obtained funds to help pharmacies get involved in providing vaccinations.
Former CMS adviser, Kocot joins Sonnenschein Nath & Rosenthal
S. Lawrence Kocot, former CMS adviser joins Sonnenschein Nath & Rosenthal
Pharmacy technician awarded Silver Star for valor
Confrontation with suicide bomber nets W.V. reservist an award for bravery.Confrontation with suicide bomber nets W.V. reservist an award for bravery.
Coalition wants e-prescribing in Medicare to be mandatory by 2010
Groups press for e-prescribing in Medicare.
Reports prompt expanded Byetta precautions
Link suspected between diabetes drug, pancreatitis.
Apria Healthcare Group, Coram to tie the knot
Apria Healthcare Group to acquire Coram.
Velcade now OK'd for patients with renal insufficiency
FDA expands label for bortezomib (Velcade) for patients with impaired kidney function.
First integrase inhibitor Isentress gets regulatory green light
Raltegravir (Isentress, Merck) receives FDA approval for HIV treatment.
Priority review of Hycamtin leads to FDA nod for SCLC
Topotecan granted FDA approval for relapsed small cell lung cancer.
Rite Aid and Lindora to open five clinics in southern California
Rite Aid and Lindora to expand California in-store clinics.
Walgreen Co. receives NABP accreditation for DMEPOS
NABP awards DMEPOS accreditation to Walgreen Co.
Homeopathic firms hope to capitalize on OTC withdrawal
Makers of homeopathic products push their cough and cold remedies in the wake of the withdrawal OTC cough and cold products for infants.
New report damning to Part D private insurers
A new report requested by Rep. Henry Waxman finds that private insurers are not operating their Medicare Part D programs efficiently.
NCPA's Roberts calls for optimism amid difficulty
NCPA CEO Bruce Roberts urges members to get more involved in medication therapy management, e-prescribing, and lobbying legislators at annual convention.
Staffing and service rose at independent pharmacies in 2006
Although the number of independent pharmacies has decreased from 2006, salary levels for pharmacists and technicians have increased.
Former airline maintenance center becomes specialty pharmacy
WellPoint opens specialty pharmacy in airport
False claims lead marshals to seize $71,000 worth of supplements
Dietary supplements confiscated by FDA
NCPA political powerhouse John Rector to retire next year
John Rector plans to step down from his position as general counsel for NCPA in 2008
Beware of new warnings for contrast agents
FDA issues new warnings about Definity and Optison contrast agents
Medicaid spending remains flat
States look to expand Medicaid benefits and eligibility as the program enrollment and spending remain low.
Consumers Union finds fault with Part D ratings
Consumers Union, publisher of Consumer Reports, criticizes the Centers for Medicare & Medicaid Service's system for rating Medicare Part D prescription drug plans as meaningless.
Outcomes upgrades MTM system
Outcomes Pharmaceutical Health Care has released a new version of its medication therapy management (MTM) systems.
Manufacturer cuts off compounding pharmacies' access to its drug
The eye care community is disconcerted by Genentech's decision to restrict access to its cancer drug Avastin.
CMS slow to investigate PDP fraud
OIG report finds the Centers for Medicare & Medicaid Services was slow to respond to fraud allegations against prescription drug plans and lacked an antifraud strategy.
MMWR reports on colchicine deaths due to compounding error
Three deaths determined to be result of colchicine toxicity
